DL
David Lebowitz Citigroup Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
29
Avg Return
Past Year
Past Year
15%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
63.3%
Neutral
30%
Negative
6.7%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
Health Information Services
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Maintained
| $84 |
20%
upside
| 3 | +30% |
0
%
| 3 Sep ‘25 1 month ago |
|
|
|
Buy
Maintained
| $84 |
40%
upside
| 4 | +12% |
0
%
| 2 Sep ‘25 1 month ago |
|
|
|
Buy
Maintained
| $48 |
79%
upside
| 1 | +11% |
0
%
| 20 Aug ‘25 1 month ago |
|
|
|
Neutral
Downgraded
| $20 |
5%
upside
| 1 | – |
–
| 15 Aug ‘25 1 month ago |
|
|
|
Buy
Maintained
| $290 |
38%
upside
| 2 | +9% |
0
%
| 8 Aug ‘25 2 months ago |
|
|
|
Buy
Maintained
| $103 |
23%
upside
| 3 | +4.8% |
0
%
| 30 Jul ‘25 2 months ago |
|
|
|
Neutral
Maintained
| $38 |
13%
upside
| 2 | – |
–
| 24 Jul ‘25 2 months ago |
|
|
|
Buy
Maintained
| $22 |
35%
upside
| 1 | +33% |
0
%
| 18 Jul ‘25 2 months ago |
|
|
|
Buy
Maintained
| $67 |
21%
upside
| 2 | +23% |
0
%
| 11 Jul ‘25 3 months ago |
|
|
|
Neutral
Upgraded
| $129 |
0%
downside
| 1 | – |
–
| 4 Jun ‘25 4 months ago |
|
|
|
Buy
Maintained
| $56 |
47%
upside
| 2 | +11% |
0
%
| 15 May ‘25 5 months ago |
|
|
|
Neutral
Maintained
| $10 |
59%
downside
| 3 | – |
–
| 9 May ‘25 5 months ago |
|
|
|
Neutral
Maintained
| $1.50 |
2%
upside
| 2 | – |
–
| 4 Mar ‘25 7 months ago |
|
|
|
Sell
Maintained
| $45 |
32%
downside
| 2 | -16% |
0
%
| 12 Feb ‘25 8 months ago |
|
|
|
Buy
Maintained
| $68 |
6%
downside
| 1 | +72% |
0
%
| 13 Nov ‘24 11 months ago |
|